MAP2K2 and cancer: At 36 dpi, 19 potential target mRNAs (e.g., tcf7l2, hpas, and map2k2) of six DEmiRNAs were associated with five enriched KEGG pathways (e.g., basal cell carcinoma, melanogenesis, and microRNAs in cancer).